Lupus nephritis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lupus nephritis}} | {{Lupus nephritis}} | ||
{{CMG}} '''Associate Editor(s)-in-Chief:''' | {{CMG}} '''Associate Editor(s)-in-Chief: [[User:Okamal|Omer Kamal, M.D.]][mailto:okamal@bidmc.harvard.edu <nowiki>[2]</nowiki>]''' | ||
==Overview== | ==Overview== |
Revision as of 17:46, 20 July 2018
Lupus nephritis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lupus nephritis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Lupus nephritis cost-effectiveness of therapy |
Risk calculators and risk factors for Lupus nephritis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
For more information:
Systemic lupus erythematosus cost-effectiveness of therapy